Discovery - University of Dundee - Online Publications

Library & Learning Centre

Nasal AMP and histamine challenge within and outside the pollen season in patients with seasonal allergic rhinitis

Standard

Nasal AMP and histamine challenge within and outside the pollen season in patients with seasonal allergic rhinitis. / Vaidyanathan, Sriram; Williamson, Peter; Clearie, Karine; Morrison, Ashley; Lipworth, Brian.

In: Journal of Allergy and Clinical Immunology, Vol. 127, No. 1, 01.2011, p. 173-203.e3.

Research output: Contribution to journal › Article

Harvard

Vaidyanathan, S, Williamson, P, Clearie, K, Morrison, A & Lipworth, B 2011, 'Nasal AMP and histamine challenge within and outside the pollen season in patients with seasonal allergic rhinitis' Journal of Allergy and Clinical Immunology, vol 127, no. 1, pp. 173-203.e3.

APA

Vaidyanathan, S., Williamson, P., Clearie, K., Morrison, A., & Lipworth, B. (2011). Nasal AMP and histamine challenge within and outside the pollen season in patients with seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology, 127(1), 173-203.e3, doi: 10.1016/j.jaci.2010.09.006

Vancouver

Vaidyanathan S, Williamson P, Clearie K, Morrison A, Lipworth B. Nasal AMP and histamine challenge within and outside the pollen season in patients with seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 2011 Jan;127(1):173-203.e3.

Author

Vaidyanathan, Sriram; Williamson, Peter; Clearie, Karine; Morrison, Ashley; Lipworth, Brian / Nasal AMP and histamine challenge within and outside the pollen season in patients with seasonal allergic rhinitis.

In: Journal of Allergy and Clinical Immunology, Vol. 127, No. 1, 01.2011, p. 173-203.e3.

Research output: Contribution to journal › Article

Bibtex - Download

@article{77b004c876354965acbcd81be50eb4df,
title = "Nasal AMP and histamine challenge within and outside the pollen season in patients with seasonal allergic rhinitis",
author = "Sriram Vaidyanathan and Peter Williamson and Karine Clearie and Ashley Morrison and Brian Lipworth",
year = "2011",
volume = "127",
number = "1",
pages = "173--203.e3",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Nasal AMP and histamine challenge within and outside the pollen season in patients with seasonal allergic rhinitis

A1 - Vaidyanathan,Sriram

A1 - Williamson,Peter

A1 - Clearie,Karine

A1 - Morrison,Ashley

A1 - Lipworth,Brian

AU - Vaidyanathan,Sriram

AU - Williamson,Peter

AU - Clearie,Karine

AU - Morrison,Ashley

AU - Lipworth,Brian

PY - 2011/1

Y1 - 2011/1

N2 - <p>Background: Nasal hyperreactivity is a prominent feature of allergic rhinitis. Variation in nasal hyperreactivity with different challenge agents in and out of the pollen season has not been examined.</p><p>Objective: We sought to compare nasal hyperreactivity with different challenge agents before, during, and after the pollen season.</p><p>Methods: Grass pollen-monosensitized patients performed cumulative-dose challenges with nasal AMP (25-800 mg . mL(-1)) and histamine (0.25-8 mg . mL(-1)) before, during, and after the grass pollen season. Outcomes included the provocative concentration of agent causing a 30% decrease in the peak nasal inspiratory flow (PNIF) (PC30), recovery profile, and diary cards.</p><p>Results: Nineteen participants completed per protocol. AMP PC30 values for PNIF worsened by 1.33 (95% CI, 0.20-2.44; P = .02) doubling dilutions during the season but recovered after the season. The AMP recovery curve showed a 214.39% difference (95% CI, -21.11% to -7.66%; P &lt; .001) during the season and remained abnormal after the season (-8.05% [95% CI, -14.78% to -1.33%; P &lt;.05). Histamine PC30 values did not change during the season, but recovery was prolonged by 214.47% (95% CI, 222.19% to -6.76%, P &lt; .001), returning to baseline values after the season. Nasal symptoms, domiciliary PNIF, and serum eosinophil-derived neurotoxin levels returned to baseline values after the season.</p><p>Conclusions: There is a reduction in AMP PC threshold but not histamine PC threshold during the pollen season, indicating that AMP is a more sensitive indicator of allergic inflammation. The residual hyperreactivity to nasal AMP, but not histamine, outside of the pollen season, seen as a persistently prolonged recovery curve, suggests the presence of primed airway mucosal mast cells, even in asymptomatic patients, and persistent activation of mediator pathways, such as cysteinyl leukotrienes. (J Allergy Clin Immunol 2011;127:173-8.)</p>

AB - <p>Background: Nasal hyperreactivity is a prominent feature of allergic rhinitis. Variation in nasal hyperreactivity with different challenge agents in and out of the pollen season has not been examined.</p><p>Objective: We sought to compare nasal hyperreactivity with different challenge agents before, during, and after the pollen season.</p><p>Methods: Grass pollen-monosensitized patients performed cumulative-dose challenges with nasal AMP (25-800 mg . mL(-1)) and histamine (0.25-8 mg . mL(-1)) before, during, and after the grass pollen season. Outcomes included the provocative concentration of agent causing a 30% decrease in the peak nasal inspiratory flow (PNIF) (PC30), recovery profile, and diary cards.</p><p>Results: Nineteen participants completed per protocol. AMP PC30 values for PNIF worsened by 1.33 (95% CI, 0.20-2.44; P = .02) doubling dilutions during the season but recovered after the season. The AMP recovery curve showed a 214.39% difference (95% CI, -21.11% to -7.66%; P &lt; .001) during the season and remained abnormal after the season (-8.05% [95% CI, -14.78% to -1.33%; P &lt;.05). Histamine PC30 values did not change during the season, but recovery was prolonged by 214.47% (95% CI, 222.19% to -6.76%, P &lt; .001), returning to baseline values after the season. Nasal symptoms, domiciliary PNIF, and serum eosinophil-derived neurotoxin levels returned to baseline values after the season.</p><p>Conclusions: There is a reduction in AMP PC threshold but not histamine PC threshold during the pollen season, indicating that AMP is a more sensitive indicator of allergic inflammation. The residual hyperreactivity to nasal AMP, but not histamine, outside of the pollen season, seen as a persistently prolonged recovery curve, suggests the presence of primed airway mucosal mast cells, even in asymptomatic patients, and persistent activation of mediator pathways, such as cysteinyl leukotrienes. (J Allergy Clin Immunol 2011;127:173-8.)</p>

KW - Nasal hyperreactivity

KW - Nasal provocation

KW - Adenosine monophosphate

KW - Histamine

KW - Peak nasal inspiratory flow rate

KW - Nasal airway resistance

KW - Adenosine monophosphate

KW - Corticosteroid response

KW - Acoustic rhinometry

KW - Consensus report

KW - Inflammation

KW - Provocation

KW - Rhinomanometry

KW - Ceitirizine

KW - Mediators

KW - Release

U2 - 10.1016/j.jaci.2010.09.006

DO - 10.1016/j.jaci.2010.09.006

M1 - Article

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 1

VL - 127

SP - 173-203.e3

ER -

Documents

DOI

Handle.net

By the same authors

From the same journal

  • Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

    Lipworth, B. & 232 others Bousquet, J., Schünemann, H. J., Samolinski, B., Demoly, P., Baena-Cagnani, C. E., Bachert, C., Bonini, S., Boulet, L. P., Bousquet, P. J., Brozek, J. L., Canonica, G. W., Casale, T. B., Cruz, A. A., Fokkens, W. J., Fonseca, J. A., Van Wijk, R. G., Grouse, L., Haahtela, T., Khaltaev, N., Kuna, P., Lockey, R. F., Lodrup Carlsen, K. C., Mullol, J., Naclerio, R., O'hehir, R. E., Ohta, K., Palkonen, S., Papadopoulos, N. G., Passalacqua, G., Pawankar, R., Price, D., Ryan, D., Simons, F. E. R., Togias, A., Williams, D., Yorgancioglu, A., Yusuf, O. M., Aberer, W., Adachi, M., Agache, I., Aït-Khaled, N., Akdis, C. A., Andrianarisoa, A., Annesi-Maesano, I., Ansotegui, I. J., Baiardini, I., Bateman, E. D., Bedbrook, A., Beghé, B., Beji, M., Bel, E. H., Ben Kheder, A., Bennoor, K. S., Bergmann, K. C., Berrissoul, F., Bieber, T., Bindslev Jensen, C., Blaiss, M. S., Boner, A. L., Bouchard, J., Braido, F., Brightling, C. E., Bush, A., Caballero, F., Calderon, M. A., Calvo, M. A., Camargos, P. A. M., Caraballo, L. R., Carlsen, K. H., Carr, W., Cepeda, A. M., Cesario, A., Chavannes, N. H., Chen, Y. Z., Chiriac, A. M., Chivato Pérez, T., Chkhartishvili, E., Ciprandi, G., Costa, D. J., Cox, L., Custovic, A., Dahl, R., Darsow, U., De Blay, F., Deleanu, D., Denburg, J. A., Devillier, P., Didi, T., Dokic, D., Dolen, W. K., Douagui, H., Dubakiene, R., Durham, S. R., Dykewicz, M. S., El-Gamal, Y., El-Meziane, A., Emuzyte, R., Fiocchi, A., Fletcher, M., Fukuda, T., Gamkrelidze, A., Gereda, J. E., González Diaz, S., Gotua, M., Guzmán, M. A., Hellings, P. W., Hellquist-Dahl, B., Horak, F., Hourihane, J. O. B., Howarth, P., Humbert, M., Ivancevich, J. C., Jackson, C., Just, J., Kalayci, O., Kaliner, M. A., Kalyoncu, A. F., Keil, T., Keith, P. K., Khayat, G., Kim, Y. Y., Koffi N'Goran, B., Koppelman, G. H., Kowalski, M. L., Kull, I., Kvedariene, V., Larenas-Linnemann, D., Le, L. T., Lemière, C., Li, J., Lieberman, P., Mahboub, B., Makela, M. J., Martin, F., Marshall, G. D., Martinez, F. D., Masjedi, M. R., Maurer, M., Mavale-Manuel, S., Mazon, A., Melen, E., Meltzer, E. O., Mendez, N. H., Merk, H., Mihaltan, F., Mohammad, Y., Morais-Almeida, M., Muraro, A., Nafti, S., Namazova-Baranova, L., Nekam, K., Neou, A., Niggemann, B., Nizankowska-Mogilnicka, E., Nyembue, T. D., Okamoto, Y., Okubo, K., Orru, M. P., Ouedraogo, S., Ozdemir, C., Panzner, P., Pali-Schöll, I., Park, H. S., Pigearias, B., Pohl, W., Popov, T. A., Postma, D. S., Potter, P., Rabe, K. F., Ratomaharo, J., Reitamo, S., Ring, J., Roberts, R., Rogala, B., Romano, A., Roman Rodriguez, M., Rosado-Pinto, J., Rosenwasser, L., Rottem, M., Sanchez-Borges, M., Scadding, G. K., Schmid-Grendelmeier, P., Sheikh, A., Sisul, J. C., Solé, D., Sooronbaev, T., Spicak, V., Spranger, O., Stein, R. T., Stoloff, S. W., Sunyer, J., Kogevinas, M., Szczeklik, A., Todo-Bom, A., Toskala, E., Tremblay, Y., Valenta, R., Valero, A. L., Valeyre, D., Valiulis, A., Valovirta, E., Van Cauwenberge, P., Vandenplas, O., Van Weel, C., Vichyanond, P., Viegi, G., Wang, D. Y., Wickman, M., Wöhrl, S., Wright, J., Yawn, B. P., Yiallouros, P. K., Zar, H. J., Zernotti, M. E., Zhong, N., Zidarn, M., Zuberbier, T., Oddie, S., Baigenzhin, A. K., Boakye, D. A., Briggs, A. H., Burney, P. G., Busse, W. W., Chuchalin, A. G., Haddad, H., Johnston, S. L., Levy, M. L., Mohammadi, A., Rezagui, D., Terreehorst, I., Warner, J. O. & Ang, C. S. Nov-2012 In : Journal of Allergy and Clinical Immunology. 130, 5, p. 1049-1062, 14 p.

    Research output: Contribution to journal › Article

  • Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency

    Kezic, S., O'Regan, G. M., Lutter, R., Jakasa, I., Koster, E. S., Saunders, S., Caspers, P., Kemperman, P. M. J. H., Puppels, G. J., Sandilands, A., Chen, H., Campbell, L. E., Kroboth, K., Watson, R., Fallon, P. G., McLean, W. H. I. & Irvine, A. D. Apr-2012 In : Journal of Allergy and Clinical Immunology. 129, 4, p. 1031-U542, 10 p.

    Research output: Contribution to journal › Article

  • Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: Relationship to disease severity

    Chaudhuri, R. , McSharry, C. , Brady, J. , Donnelly, I. , Grierson, C. , McGuinness, S. , Jolly, L. , Weir, C. J. , Messow, C. M. , Spears, M. , Miele, G. , Nocka, K. , Crowther, D. , Thompson, J. , Brannigan, M. , Lafferty, J. , Sproule, M. , MacNee, W. , Connell, M. , Murchison, J. T. & 4 others Shepherd, M. C., Feuerstein, G., Miller, D. K. & Thomson, N. C. Mar-2012 In : Journal of Allergy and Clinical Immunology. 129, 3, p. 655-U106, 17 p.

    Research output: Contribution to journal › Article

  • The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort

    Margolis, D. J., Apter, A. J., Gupta, J., Hoffstad, O., Papadopoulos, M., Campbell, L. E., Sandilands, A., McLean, W. H. I., Rebbeck, T. R. & Mitra, N. 2012 In : Journal of Allergy and Clinical Immunology. 130, 4, p. 912-917, 6 p.

    Research output: Contribution to journal › Article

  • Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy

    Brown, S. J. , Asai, Y. , Cordell, H. J. , Campbell, L. E. , Zhao, Y. , Liao, H. , Northstone, K. , Henderson, J. , Alizadehfar, R. , Ben-Shoshan, M. , Morgan, K. , Roberts, G. , Masthoff, L. J. N. , Pasmans, S. G. M. A. , van den Akker, P. C. , Wijmenga, C. , Hourihane, J. O. B. , Palmer, C. N. A. , Lack, G. , Clarke, A. & 3 others Hull, P. R., Irvine, A. D. & McLean, W. H. I. Mar-2011 In : Journal of Allergy and Clinical Immunology. 127, 3, p. 661-667, 7 p.

    Research output: Contribution to journal › Article

Library & Learning Centre

Contact | Accessibility | Policy